WATSON 461
Pill imprint WATSON 461 has been identified as Glipizide 10 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy.
Glipizide 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Glipizide Images
- Imprint:
-
WATSON 461
- Strength:
- 10 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
croscarmellose sodium
lactose anhydrous
microcrystalline cellulose
corn starch
stearic acid
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Laboratories, Inc.
- National Drug Code (NDC):
- 00591-0461
| NDC Code | Manufacturer / Repackager |
|---|---|
| 63739-0117 | McKesson Packaging Services |
| 54569-3842 | A S Medication Solutions LLC (repackager) |
| 67544-0129 | Prepak Systems Inc (repackager) |
| 16590-0287 | Stat RX USA LLC (repackager) |
| 68258-1013 | Dispensing Solutions Inc. (repackager) |
| 66336-0662 | Dispensing Solutions Inc. (repackager) |
| 58016-0376 | Southwood Pharmaceuticals Inc (repackager) |
| 63874-0432 | Altura Pharmaceuticals Inc (repackager) |
| 54868-3319 | Physicians Total Care Inc (repackager) |
| 21695-0470 | Rebel Distributors Corp (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Glipizide resources
- Glipizide
- Glipizide (Wolters Kluwer)
- Glipizide Extended-Release Tablets (Wolters Kluwer)
- glipizide (Cerner Multum)
- glipizide (Micromedex) - Includes Dosage Information
- Glipizide (AHFS DI)
- Glipizide (FDA)
- Glipizide ER (FDA)
- Glipizide Tablets (FDA)
- Glipizide (Wolters Kluwer)
Search Again
